ALKS: Alkermes plc
ALKS exchange rate has changed by 0.99% for today. During the day, the instrument was traded at a low of 27.42 and at a high of 28.75.
Follow Alkermes plc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALKS News
- Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
- H.C. Wainwright lowers Alkermes stock price target on revenue guidance
- Alkermes plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ALKS) 2026-02-25
- Alkermes (ALKS) Reports Q4 Earnings: What Key Metrics Have to Say
- Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates
- Alkermes stock up over 3% after beating revenue estimates, guides above consensus
- Alkermes Plc earnings missed by $0.12, revenue topped estimates
- Alkermes CEO Richard Pops to retire after 35 years, Jackson named successor
- Wall Street's Insights Into Key Metrics Ahead of Alkermes (ALKS) Q4 Earnings
- BHC Stock Down on Q4 Earnings Miss, Salix Drives Revenue Growth
- ImmunityBio Wins EU Nod for Bladder Cancer Combo Therapy, Stock Up
- FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
- Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark
- IXJ ETF: Healthcare Sector Dashboard For February (NYSEARCA:IXJ)
- EU Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
- Is Alkermes (ALKS) Stock Outpacing Its Medical Peers This Year?
- Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo
- Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report?
- Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
- SNY Stock Falls After Board Suddenly Makes Leadership Change
- VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales
- Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss
- Ultragenyx Q4 Loss Wider Than Expected, Revenues Increase Y/Y
- NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia
Frequently Asked Questions
What is ALKS stock price today?
Alkermes plc stock is priced at 28.63 today. It trades within 27.42 - 28.75, yesterday's close was 28.35, and trading volume reached 4581. The live price chart of ALKS shows these updates.
Does Alkermes plc stock pay dividends?
Alkermes plc is currently valued at 28.63. Dividend policy depends on the company, while investors also watch -13.27% and USD. View the chart live to track ALKS movements.
How to buy ALKS stock?
You can buy Alkermes plc shares at the current price of 28.63. Orders are usually placed near 28.63 or 28.93, while 4581 and 2.58% show market activity. Follow ALKS updates on the live chart today.
How to invest into ALKS stock?
Investing in Alkermes plc involves considering the yearly range 25.16 - 36.32 and current price 28.63. Many compare -2.25% and -4.79% before placing orders at 28.63 or 28.93. Explore the ALKS price chart live with daily changes.
What are Alkermes plc stock highest prices?
The highest price of Alkermes plc in the past year was 36.32. Within 25.16 - 36.32, the stock fluctuated notably, and comparing with 28.35 helps spot resistance levels. Track Alkermes plc performance using the live chart.
What are Alkermes plc stock lowest prices?
The lowest price of Alkermes plc (ALKS) over the year was 25.16. Comparing it with the current 28.63 and 25.16 - 36.32 shows potential long-term entry points. Watch ALKS moves on the chart live for more details.
When did ALKS stock split?
Alkermes plc has gone through stock splits historically. These changes are visible in , 28.35, and -13.27% after corporate actions.
- Previous Close
- 28.35
- Open
- 27.91
- Bid
- 28.63
- Ask
- 28.93
- Low
- 27.42
- High
- 28.75
- Volume
- 4.581 K
- Daily Change
- 0.99%
- Month Change
- -2.25%
- 6 Months Change
- -4.79%
- Year Change
- -13.27%